Exact Sciences Corp at Goldman Sachs Global Healthcare Conference Transcript
We can look to get started here. Thanks for being here.
I am the -- Patrick Donnelly, the tools and diagnostics analyst here at Goldman. Happy to have Jeff Elliott, CFO of Exact science, with us today.
It's open Q&A, so feel free. If you have any questions, just raise your hand.
But Jeff, maybe just to start, if you can kind of talk through the most recent quarter, obviously great results from you guys so far this year. Maybe just recap what you're seeing out there and then we will dive right into the Q&A.
Sure, happy to. And Patrick, thanks for having us back here. It's great to be back at the Goldman Sachs conference.
So Q1 was another good quarter for Exact Sciences. We had about 80% revenue growth and we ended the quarter with about 4.5% market share. So this is a huge market, which I think we'll talk more about. Today, there are over 85 million people in the U.S. who are on
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
